Literature DB >> 6236976

Interaction of calmodulin with muscle phosphofructokinase. Interplay with metabolic effectors of the enzyme under physiological conditions.

G W Mayr.   

Abstract

The hysteretic calmodulin-induced inactivation of muscle phosphofructokinase and the calmodulin-mediated reactivation are essentially dependent on environmental conditions. The interplay of calmodulin during these reactions and at allosteric conditions with Mg . ATP, fructose 6-phosphate, adenosine 5'-[beta, gamma-imido]triphosphate and with the allosteric effectors AMP, ADP, fructose 1,6-bisphosphate, fructose 2,6-bisphosphate and glucose 1,6-bisphosphate was studied by two techniques. (a) A two-step technique with a preincubation of enzyme, calmodulin and effectors in close to physiological concentrations before dilution into an optimal activity assay. It reveals aggregation and slowly reversible conformation changes. (b) A direct assay of dilute enzyme at allosteric conditions. Dominating in the interplay of calmodulin with metabolic effectors is the competitive-like action of calmodulin on Mg . ATP binding to the regulatory sites of the enzyme. At high enzyme concentrations in the absence of hexose phosphates, i.e. at noncatalytic conditions calmodulin counteracts the stabilization of the highly active tetrameric form caused by Mg . ATP. In the allosteric assay it counteracts the ATP-induced allosteric inhibition. In both cases calmodulin acts synergistic with AMP and ADP. To a minor degree calmodulin also counteracts the stabilization of the tetrameric form caused by fructose 6-phosphate and hexose bisphosphate, now however antagonistically to AMP and ADP. By the demonstrated interactions the enzyme can be slowly and hysteretically shifted between an active tetrameric and an inactive dimeric state under control metabolic conditions and of Ca2+ and calmodulin. Resting conditions will inactivate and high contractile activity reactivate available enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236976     DOI: 10.1111/j.1432-1033.1984.tb08401.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery.

Authors:  B Quistorff; L Johansen; K Sahlin
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

2.  Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism.

Authors:  Christopher M Jenkins; Jingyue Yang; Harold F Sims; Richard W Gross
Journal:  J Biol Chem       Date:  2011-01-23       Impact factor: 5.157

3.  Smooth muscle myosin light chain kinase, supramolecular organization, modulation of activity, and related conformational changes.

Authors:  A M Filenko; V M Danilova; A Sobieszek
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

4.  Inositol 1,4-bisphosphate is an allosteric activator of muscle-type 6-phosphofructo-1-kinase.

Authors:  G W Mayr
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

5.  Inactivation of maize leaf phosphoenolpyruvate carboxylase by the binding to chloroplast membranes.

Authors:  M X Wu; R T Wedding
Journal:  Plant Physiol       Date:  1992-09       Impact factor: 8.340

6.  Crystallization and preliminary crystallographic analysis of human muscle phosphofructokinase, the main regulator of glycolysis.

Authors:  Marco Kloos; Antje Brüser; Jürgen Kirchberger; Torsten Schöneberg; Norbert Sträter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-25       Impact factor: 1.056

7.  Changes in glucose 1,6-bisphosphate content in rat skeletal muscle during contraction.

Authors:  A M Bassols; J Carreras; R Cussó
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

8.  The interaction of troponin C with phosphofructokinase. Comparison with calmodulin.

Authors:  J Q Lan; R F Steiner
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.